Mesco Pharmaceuticals Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported loss before exceptional items and tax, finance costs & exceptional items was INR 106,986.00 compared INR 84,550.00 a year ago. Loss before tax was INR 106,986.00 compared to INR 84,550.00 a year ago. Loss for the period was INR 106,986.00 compared to INR 84,550.00 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.01 per share compared to INR 0.00 a year ago. For the nine months, the company reported loss before exceptional items and tax, finance costs & exceptional items was INR 743,930.20 compared INR 238,115.00 a year ago. Loss before tax was INR 743,930.20 compared INR 238,115.00 a year ago. Loss for the period was INR 743,930.20 compared INR 238,115.00 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.04 per share compared to INR 0.01 a year ago.